Pei-Hsin Cheng

Scientist with a belief in “giving one shot, curing it forever”, seeking to facilitate discoveries from bench to bedside. Working on gene therapy for over 15 years, including 7 plus years of extensive experience in AAV production, purification, quality management, and characterization. Responsible for the supply of research-grade AAV preps for research team and the initial vector development for 1 patent under application and 2 upcoming hemophilia clinical trials.